Shopping Cart 0
Cart Subtotal
AED 0

Global Plasma Fractionation Market (By Product Type- Intravenous Immunoglobulin (IVIG), Albumin, Protease Inhibitor, Subcutaneous Immunoglobulin (SCIG), and Others. By Application- Hematology, Critical Care, Neurology, Rheumatology, and Others)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017 - 2025

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 17598

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 24938

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 28608

Details

The report covers the analysis and forecast of the plasma fractionation market on global as well as regional level. The study provides historic data of 2016 along with the forecast for the period between 2017 and 2025 based on revenue (USD Mn).
 
The study provides a detailed view of the plasma fractionation market, by segmenting it based on by product type, application, and regional demand. Robust development of plasma products in the past several years have propelled the demand for the market. Moreover, growing usage of immunoglobulin in several therapeutic areas is another prime factor driving the market demand. Additionally, growing awareness, and demand for plasma fractionation products with the adoption of technological advancement fuel the demand of this market.
Regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Middle East and Africa and Latin America. The segmentation also includes by product type, and application in all regions. These include different business strategies adopted by the leading players and their recent developments.
 
A comprehensive analysis of the market dynamics that is inclusive of market drivers, restraints, and opportunities is part of the report. Additionally, the report includes potential opportunities in the plasma fractionation market at the global and regional levels. Market dynamics are the factors which impact the market growth, so their analysis helps understand the ongoing trends of the global market. Therefore, the report provides the forecast of the global market for the period from 2017 to 2025, along with offering an inclusive study of the plasma fractionation market.
 
The report provides the size of the plasma fractionation market in 2017 and the forecast for the next eight years up to 2025. The size of the global plasma fractionation market is provided in terms of revenue. Market revenue is defined in USD Mn. The market dynamics prevalent in North America, Europe, Asia Pacific, Middle East and Africa and Latin America has been taken into account in estimating the growth of the global market.
 
Market estimates for this study have been based on revenue being derived through regional pricing trends. The plasma fractionation market has been analyzed based on expected demand. Bottom-up approach is done to estimate the global revenue of the dental implants and prosthes is market, split into regions. Based on product type, and application the individual revenues from all the regions is summed up to achieve the global revenue for plasma fractionation. Companies were considered for the market share analysis, based on their innovation and revenue generation. In the absence of specific data related to the sales of plasma fractionation several privately held companies, calculated assumptions have been made in view of the company's penetration and regional presence.
 
The report covers a detailed competitive outlook that includes the market share and company profiles of key players operating in the global market. Key players profiled in the report include Biotest AG, Baxter International Inc., Bio Product Laboratory, CSL Limited, Grifols, Japan Blood Products organization, Octapharma AG, Shanghai Raas Blood Products, and Sanquin.
The global plasma fractionation market has been segmented into:
Global Plasma Fractionation Market: By Product Type
Intravenous immunoglobulin (IVIG)
Albumin
Protease inhibitor
Subcutaneous immunoglobulin (SCIG)
Others
Global Plasma Fractionation Market: By Application
Hematology
Critical care
Neurology
Rheumatology
Others
Global Plasma Fractionation Market: By Geography
North America
o U.S.
o Canada
o Mexico
Europe
o U.K.
o France
o Germany
o Italy
o Rest of Europe
Asia Pacific
o India
o China
o Japan
o Rest of Asia Pacific
Middle East and Africa
o South Africa
o Rest of Middle East and Africa
Latin America
o Brazil
o Rest of Latin America
READ MORE

Table Of Content

Scope

1 RESEARCH METHODOLOGY, ASSUMPTIONS AND ACRONYMS

2 EXECUTIVE SUMMARY

2.1 GLOBAL PLASMA FRACTIONATION MARKET

3 GLOBAL PLASMA FRACTIONATION MARKET-MARKET OVERVIEW

3.1 INTRODUCTION

3.1.1 GLOBAL PLASMA PLASMA FRACTIONATION REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET

3.1.2 GLOBAL PLASMA PLASMA FRACTIONATION SNAPSHOT

4 GLOBAL PLASMA PLASMA FRACTIONATION OVERVIEW- BY PRODUCT TYPE

4.1 INTRODUCTION

4.1.1 GLOBAL PLASMA PLASMA FRACTIONATION REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY PRODUCT TYPE

4.1.1.1 INTRAVENOUS IMMUNOGLOBULIN (IVIG)

4.1.1.2 ALBUMIN

4.1.1.3 PROTEASE INHIBITOR

4.1.1.4 SUBCUTANEOUS IMMUNOGLOBULIN (SCIG)

4.1.1.5 OTHERS

5 GLOBAL PLASMA PLASMA FRACTIONATION ANALYSIS AND FORECAST, BY APPLICATION

5.1 INTRODUCTION

5.1.1 GLOBAL PLASMA PLASMA FRACTIONATION REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY APPLICATION

5.1.1.1 HEMATOLOGY

5.1.1.2 CRITICAL CARE

5.1.1.3 NEUROLOGY

5.1.1.4 RHEUMATOLOGY

5.1.1.5 OTHERS

6 GLOBAL PLASMA PLASMA FRACTIONATION REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET, BY REGION

6.1 INTRODUCTION

6.2 KEY TAKEWAYS

7 NORTH AMERICA PLASMA PLASMA FRACTIONATION REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET

7.1 MARKET DYNAMICS

7.1.1 DRIVERS

7.1.2 RESTRAINTS

7.1.3 OPPORTUNITIES

7.2 NORTH AMERICA PLASMA PLASMA FRACTIONATION ANALYSIS- BY PRODUCT TYPE

7.3 NORTH AMERICA PLASMA PLASMA FRACTIONATION ANALYSIS- BY APPLICATION

7.4 U.S.

7.5 CANADA

7.6 MEXICO

8 EUROPE PLASMA PLASMA FRACTIONATION REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET

8.1 MARKET DYNAMICS

8.1.1 DRIVERS

8.1.2 RESTRAINTS

8.1.3 OPPORTUNITIES

8.2 EUROPE PLASMA PLASMA FRACTIONATION ANALYSIS- BY PRODUCT TYPE

8.3 EUROPE PLASMA PLASMA FRACTIONATION ANALYSIS- BY APPLICATION

8.4 U.K.

8.5 FRANCE

8.6 GERMANY

8.7 ITALY

8.8 SPAIN

8.9 REST OF EUROPE

9 ASIA PACIFIC PLASMA PLASMA FRACTIONATION REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET

9.1 MARKET DYNAMICS

9.1.1 DRIVERS

9.1.2 RESTRAINTS

9.1.3 OPPORTUNITIES

9.2 ASIA PACIFIC PLASMA PLASMA FRACTIONATION ANALYSIS- BY PRODUCT TYPE

9.3 ASIA PACIFIC PLASMA PLASMA FRACTIONATION ANALYSIS- BY APPLICATION

9.4 INDIA

9.5 CHINA

9.6 JAPAN

9.7 REST OF ASIA PACIFIC

10 MIDDLE EAST AND AFRICA (MEA) PLASMA PLASMA FRACTIONATION REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET

10.1 MARKET DYNAMICS

10.1.1 DRIVERS

10.1.2 RESTRAINTS

10.1.3 OPPORTUNITIES

10.2 MEA PLASMA PLASMA FRACTIONATION ANALYSIS- BY PRODUCT TYPE

10.3 MEA PLASMA PLASMA FRACTIONATION ANALYSIS- BY APPLICATION

10.4 SOUTH AFRICA

10.5 REST OF MIDDLE EAST AND AFRICA

11 LATIN AMERICA PLASMA PLASMA FRACTIONATION REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET

11.1 MARKET DYNAMICS

11.1.1 DRIVERS

11.1.2 RESTRAINTS

11.1.3 OPPORTUNITIES

11.2 LATIN AMERICA PLASMA PLASMA FRACTIONATION ANALYSIS- BY PRODUCT TYPE

11.3 LATIN AMERICA PLASMA PLASMA FRACTIONATION ANALYSIS- BY APPLICATION

11.4 BRAZIL

11.5 REST OF LATIN AMERICA

12 COMPETATIVE LANDSCAPE

12.1 GLOBAL PLASMA PLASMA FRACTIONATION -COMPANY MARKET SHARE ANALYSIS

13 COMPANY PROFILES: (REVENUE, PRODUCT TYPES/BRAND OFFERINGS, COMPANY HIGHLIGHTS)

13.1 BIOTEST AG

13.2 BAXTER INTERNATIONAL INC.

13.3 BIO PRODUCT LABORATORY

13.4 CSL LIMITED

13.5 GRIFOLS

13.6 GREEN CROSS CORPORATION

13.7 JAPAN BLOOD PRODUCTS ORGANIZATION

13.8 OCTAPHARMA AG

13.9 SHANGHAI RAAS BLOOD PRODUCTS

13.10 SANQUIN

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

The report covers the analysis and forecast of the plasma fractionation market on global as well as regional level. The study provides historic data of 2016 along with the forecast for the period between 2017 and 2025 based on revenue (USD Mn).
 
The study provides a detailed view of the plasma fractionation market, by segmenting it based on by product type, application, and regional demand. Robust development of plasma products in the past several years have propelled the demand for the market. Moreover, growing usage of immunoglobulin in several therapeutic areas is another prime factor driving the market demand. Additionally, growing awareness, and demand for plasma fractionation products with the adoption of technological advancement fuel the demand of this market.
Regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Middle East and Africa and Latin America. The segmentation also includes by product type, and application in all regions. These include different business strategies adopted by the leading players and their recent developments.
 
A comprehensive analysis of the market dynamics that is inclusive of market drivers, restraints, and opportunities is part of the report. Additionally, the report includes potential opportunities in the plasma fractionation market at the global and regional levels. Market dynamics are the factors which impact the market growth, so their analysis helps understand the ongoing trends of the global market. Therefore, the report provides the forecast of the global market for the period from 2017 to 2025, along with offering an inclusive study of the plasma fractionation market.
 
The report provides the size of the plasma fractionation market in 2017 and the forecast for the next eight years up to 2025. The size of the global plasma fractionation market is provided in terms of revenue. Market revenue is defined in USD Mn. The market dynamics prevalent in North America, Europe, Asia Pacific, Middle East and Africa and Latin America has been taken into account in estimating the growth of the global market.
 
Market estimates for this study have been based on revenue being derived through regional pricing trends. The plasma fractionation market has been analyzed based on expected demand. Bottom-up approach is done to estimate the global revenue of the dental implants and prosthes is market, split into regions. Based on product type, and application the individual revenues from all the regions is summed up to achieve the global revenue for plasma fractionation. Companies were considered for the market share analysis, based on their innovation and revenue generation. In the absence of specific data related to the sales of plasma fractionation several privately held companies, calculated assumptions have been made in view of the company's penetration and regional presence.
 
The report covers a detailed competitive outlook that includes the market share and company profiles of key players operating in the global market. Key players profiled in the report include Biotest AG, Baxter International Inc., Bio Product Laboratory, CSL Limited, Grifols, Japan Blood Products organization, Octapharma AG, Shanghai Raas Blood Products, and Sanquin.
The global plasma fractionation market has been segmented into:
Global Plasma Fractionation Market: By Product Type
Intravenous immunoglobulin (IVIG)
Albumin
Protease inhibitor
Subcutaneous immunoglobulin (SCIG)
Others
Global Plasma Fractionation Market: By Application
Hematology
Critical care
Neurology
Rheumatology
Others
Global Plasma Fractionation Market: By Geography
North America
o U.S.
o Canada
o Mexico
Europe
o U.K.
o France
o Germany
o Italy
o Rest of Europe
Asia Pacific
o India
o China
o Japan
o Rest of Asia Pacific
Middle East and Africa
o South Africa
o Rest of Middle East and Africa
Latin America
o Brazil
o Rest of Latin America
READ MORE

Scope

1 RESEARCH METHODOLOGY, ASSUMPTIONS AND ACRONYMS

2 EXECUTIVE SUMMARY

2.1 GLOBAL PLASMA FRACTIONATION MARKET

3 GLOBAL PLASMA FRACTIONATION MARKET-MARKET OVERVIEW

3.1 INTRODUCTION

3.1.1 GLOBAL PLASMA PLASMA FRACTIONATION REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET

3.1.2 GLOBAL PLASMA PLASMA FRACTIONATION SNAPSHOT

4 GLOBAL PLASMA PLASMA FRACTIONATION OVERVIEW- BY PRODUCT TYPE

4.1 INTRODUCTION

4.1.1 GLOBAL PLASMA PLASMA FRACTIONATION REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY PRODUCT TYPE

4.1.1.1 INTRAVENOUS IMMUNOGLOBULIN (IVIG)

4.1.1.2 ALBUMIN

4.1.1.3 PROTEASE INHIBITOR

4.1.1.4 SUBCUTANEOUS IMMUNOGLOBULIN (SCIG)

4.1.1.5 OTHERS

5 GLOBAL PLASMA PLASMA FRACTIONATION ANALYSIS AND FORECAST, BY APPLICATION

5.1 INTRODUCTION

5.1.1 GLOBAL PLASMA PLASMA FRACTIONATION REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY APPLICATION

5.1.1.1 HEMATOLOGY

5.1.1.2 CRITICAL CARE

5.1.1.3 NEUROLOGY

5.1.1.4 RHEUMATOLOGY

5.1.1.5 OTHERS

6 GLOBAL PLASMA PLASMA FRACTIONATION REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET, BY REGION

6.1 INTRODUCTION

6.2 KEY TAKEWAYS

7 NORTH AMERICA PLASMA PLASMA FRACTIONATION REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET

7.1 MARKET DYNAMICS

7.1.1 DRIVERS

7.1.2 RESTRAINTS

7.1.3 OPPORTUNITIES

7.2 NORTH AMERICA PLASMA PLASMA FRACTIONATION ANALYSIS- BY PRODUCT TYPE

7.3 NORTH AMERICA PLASMA PLASMA FRACTIONATION ANALYSIS- BY APPLICATION

7.4 U.S.

7.5 CANADA

7.6 MEXICO

8 EUROPE PLASMA PLASMA FRACTIONATION REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET

8.1 MARKET DYNAMICS

8.1.1 DRIVERS

8.1.2 RESTRAINTS

8.1.3 OPPORTUNITIES

8.2 EUROPE PLASMA PLASMA FRACTIONATION ANALYSIS- BY PRODUCT TYPE

8.3 EUROPE PLASMA PLASMA FRACTIONATION ANALYSIS- BY APPLICATION

8.4 U.K.

8.5 FRANCE

8.6 GERMANY

8.7 ITALY

8.8 SPAIN

8.9 REST OF EUROPE

9 ASIA PACIFIC PLASMA PLASMA FRACTIONATION REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET

9.1 MARKET DYNAMICS

9.1.1 DRIVERS

9.1.2 RESTRAINTS

9.1.3 OPPORTUNITIES

9.2 ASIA PACIFIC PLASMA PLASMA FRACTIONATION ANALYSIS- BY PRODUCT TYPE

9.3 ASIA PACIFIC PLASMA PLASMA FRACTIONATION ANALYSIS- BY APPLICATION

9.4 INDIA

9.5 CHINA

9.6 JAPAN

9.7 REST OF ASIA PACIFIC

10 MIDDLE EAST AND AFRICA (MEA) PLASMA PLASMA FRACTIONATION REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET

10.1 MARKET DYNAMICS

10.1.1 DRIVERS

10.1.2 RESTRAINTS

10.1.3 OPPORTUNITIES

10.2 MEA PLASMA PLASMA FRACTIONATION ANALYSIS- BY PRODUCT TYPE

10.3 MEA PLASMA PLASMA FRACTIONATION ANALYSIS- BY APPLICATION

10.4 SOUTH AFRICA

10.5 REST OF MIDDLE EAST AND AFRICA

11 LATIN AMERICA PLASMA PLASMA FRACTIONATION REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET

11.1 MARKET DYNAMICS

11.1.1 DRIVERS

11.1.2 RESTRAINTS

11.1.3 OPPORTUNITIES

11.2 LATIN AMERICA PLASMA PLASMA FRACTIONATION ANALYSIS- BY PRODUCT TYPE

11.3 LATIN AMERICA PLASMA PLASMA FRACTIONATION ANALYSIS- BY APPLICATION

11.4 BRAZIL

11.5 REST OF LATIN AMERICA

12 COMPETATIVE LANDSCAPE

12.1 GLOBAL PLASMA PLASMA FRACTIONATION -COMPANY MARKET SHARE ANALYSIS

13 COMPANY PROFILES: (REVENUE, PRODUCT TYPES/BRAND OFFERINGS, COMPANY HIGHLIGHTS)

13.1 BIOTEST AG

13.2 BAXTER INTERNATIONAL INC.

13.3 BIO PRODUCT LABORATORY

13.4 CSL LIMITED

13.5 GRIFOLS

13.6 GREEN CROSS CORPORATION

13.7 JAPAN BLOOD PRODUCTS ORGANIZATION

13.8 OCTAPHARMA AG

13.9 SHANGHAI RAAS BLOOD PRODUCTS

13.10 SANQUIN

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS